首页 | 本学科首页   官方微博 | 高级检索  
     


Seroresponses and safety of 13‐valent pneumococcal conjugate vaccination in kidney transplant recipients
Authors:Claire Dendle  Rhonda L. Stuart  Kevan R. Polkinghorne  Anne Balloch  John Kanellis  Johnathan Ling  Megan Kummrow  Chelsea Moore  Karin Thursky  Jim Buttery  Kim Mulholland  Poh‐Yi Gan  Stephen Holdsworth  William R. Mulley
Affiliation:1. Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University and Monash Infectious Diseases, Monash Health, Clayton, Vic., Australia;2. Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, Clayton, Vic., Australia;3. Department of Nephrology, Monash Medical Centre, Clayton, Vic., Australia;4. Department of Epidemiology and Preventive Medicine, Monash University, Prahran, Vic., Australia;5. Murdoch Children's Research Institute, Parkville, Vic., Australia;6. Victorian Transplantation and Immunogenetics Service, West Melbourne, Vic., Australia;7. University of Melbourne, Parkville, Vic., Australia;8. Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic., Australia;9. Department of Infection and Immunity, Monash Children's Hospital, Monash Health, Melbourne, Vic., Australia
Abstract:
Keywords:kidney transplantation  luminex technology  pneumococcal antigen  serotype‐specific antibody response
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号